Clin2
NCT06940011Possibly a fitRecruiting

Endocalyx for hard-to-treat high blood pressure

Treatment Resistant Hypertension

Part of Heart & circulation clinical trials.

This trial tests a new treatment called Endocalyx for people whose high blood pressure doesn't get better with multiple medications. It aims to see if Endocalyx can help lower blood pressure when standard medicines aren't enough.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
64 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • Your blood pressure is still high (140/90 or above) despite taking at least 3 different blood pressure medicines, including a water pill.
  • You have been on the same blood pressure medications for at least 3 weeks.
  • You are 18 years or older.
  • Your kidney function is not severely reduced (eGFR above 20).
  • You do not have a known cause for high blood pressure (like a kidney or hormone problem).
  • You have not had a heart attack, stroke, or heart surgery in the last 3 months.
  • You are not allergic to seaweed, corn, artichoke, grape, melon, milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, or soy.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07758634Recruiting· Phase 1/Phase 2
Study of an experimental treatment for high blood pressure

This trial tests a new treatment called CTX340 for high blood pressure that is hard to control even with multiple medications. The study aims to see if it is safe and effective.

Port Orange, Florida
NCT07654140Recruiting· Phase 2
Testing a new drug for uncontrolled high blood pressure

This trial tests a new drug called SAL0140 for people whose high blood pressure is not controlled by current treatments. It may help lower blood pressure when other medications haven't worked well enough.

Beijing, Beijing Municipality
NCT06343298Recruiting· Phase 2
Study of manp for hard-to-control high blood pressure

This study tests a new investigational drug called MANP to see if it can lower blood pressure in people whose blood pressure stays high even when they are already taking several medications. If it works, this drug might offer a new option for people with difficult-to-control hypertension.

Little Rock, Arkansas
NCT07835984Not yet recruiting· Phase 2
Add-on treatment for high blood pressure not controlled by current pills

This trial tests a new medicine, GW906, given as an injection alongside your current blood pressure pills. It aims to help people whose blood pressure is still too high even with one or two medications.

Hangzhou, Zhejiang
NCT07708441Not yet recruiting· Phase 2/Phase 3
Study of an experimental drug for hard-to-treat high blood pressure

This study tests an investigational drug called HRS-1780 for people with high blood pressure that is not well controlled or is resistant to treatment. The purpose is to see if it can lower blood pressure more effectively than current options.

Chongqing, Chongqing Municipality
NCT06282107Not yet recruiting
A new treatment for hard-to-control high blood pressure

This study tests a new treatment (called BiSAAE) for people whose blood pressure stays high despite taking several medicines. It aims to see if it can safely lower blood pressure better than current options.

Hear when a new Treatment Resistant Hypertension trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.